Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
Sponsor: Hoffmann-La Roche
Summary
This study will assess long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with Atopic Dermatitis (AD) who participated in previous afimkibart clinical trials.
Official title: An Extension Study To Evaluate the Long-Term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Atopic Dermatitis Who Participated in Previous Afimkibart Clinical Trials
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-01-08
Completion Date
2033-03-01
Last Updated
2026-05-11
Healthy Volunteers
No
Conditions
Interventions
Afimkibart
Afimkibart SC injection will be administered as per the schedule defined in the protocol.
Locations (14)
Hamilton Research, LLC
Alpharetta, Georgia, United States
Revival Research Institute, LLC
Troy, Michigan, United States
Best Skin Research LLC
Camp Hill, Pennsylvania, United States
Irmandade Da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A
Rio de Janeiro, Brazil
DermEffects
London, Ontario, Canada
DermEdge
Mississauga, Ontario, Canada
Dermatologikum Hamburg Gemeinschaftspraxis GbR
Hamburg, Germany
Centrum Medyczne Pratia Katowice I
Katowice, Silesian Voivodeship, Poland
Centrum Medyczne Pratia Gdynia
Gdynia, Poland
Specjalistyczny Gabinet Dermatologiczny dr n. med. Pawel Brzewski
Krakow, Poland
Centrum Nowoczesnych Terapii "Dobry Lekarz"
Krakow, Poland
Uniwersytecki Szpital Kliniczny im.Fryderyka Chopina w Rzeszowie
Rzeszów, Poland
Klinika Ambroziak Dermatologia
Warsaw, Poland